A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity-Reference-Cited by-同舟云学术

A TGFβ-Responsive Gene Signature Is Associated with a Subset of Diffuse Scleroderma with Increased Disease Severity

Published:2010-03 Issue:3 Volume:130 Page:694-705
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Sargent Jennifer L.,Milano Ausra,Bhattacharyya Swati,Varga John,Connolly M. Kari,Chang Howard Y.,Whitfield Michael L.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference57 articles.

1. Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis;Akhmetshina;FASEB J,2008

2. The diagnosis and classification of scleroderma (systemic sclerosis);Barnett;Postgrad Med J,1988

3. A survival study of patients with scleroderma diagnosed over 30 years (1953–1983): the value of a simple cutaneous classification in the early stages of the disease;Barnett;J Rheumatol,1988

4. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis;Baroni;N Engl J Med,2006

5. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching;Chambers;Am J Pathol,2003

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RUNX1 is Expressed in a Subpopulation of Dermal Fibroblasts and Higher RUNX1 Levels are Associated with the Severity of Systemic Sclerosis;2024-04-05

2. NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy;Journal of Clinical Investigation;2024-04-02

3. Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosis;Journal of Clinical Investigation;2024-03-26

4. Isoform-selective TGF-β3 inhibition for systemic sclerosis;Med;2024-02

5. Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis;Journal of Investigative Dermatology;2023-10